Giant cell tumor occurring in familial Paget's disease of bone: Report of clinical characteristics and linkage analysis of a large pedigree

Journal of Bone and Mineral Research

Volumn 28, Issue 2, 2013, Pages 341-350

  Gianfrancesco, Fernando ^a   Rendina, Domenico ^b   Merlotti, Daniela ^c   Esposito, Teresa ^a   Amyere, Mustapha ^d   Formicola, Daniela ^a   Muscariello, Riccardo ^b   De Filippo, Gianpaolo ^b   Strazzullo, Pasquale ^b   Nuti, Ranuccio ^c   Vikkula, Mikka ^d   Gennari, Luigi ^c  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d DE DUVE INSTITUTE   (Belgium)

Author keywords

cardiovascular disease; genetics of Paget's disease of bone; giant cell tumor; Paget's disease of bone

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CLODRONIC ACID; CYTOKINE RECEPTOR; NERIDRONIC ACID; OPTINEURIN; OSTEOPROTEGERIN; PAMIDRONIC ACID; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SQSTM1 PROTEIN; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE MALFORMATION; BONE PAIN; CANCER PATIENT; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 20; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FAMILIAL DISEASE; FAMILY; FRACTURE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GIANT CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PAGET BONE DISEASE; PEDIGREE; PHENOTYPE; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; FEMALE; GENETIC LINKAGE; GEOGRAPHY; GIANT CELL TUMORS; HUMANS; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; PEDIGREE; PHENOTYPE;

EID: 84872446898     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1750     Document Type: Article

References (35)

1. Roodman GD, Windle JJ., Paget disease of bone. J Clin Invest. 2005; 115: 200-8.
2. Ralston SH, Langston AL, Reid IR., Pathogenesis and management of Paget's disease of bone. Lancet. 2008; 72: 155-63.
3. Singer FR., The etiology of Paget's disease of bone: viral and genetic interactions. Cell Metab. 2011; 13: 5-6.
4. Siris ES, Ottman R, Flaster E, Kelsey JL., Familial aggregation of Paget's disease of bone. J Bone Miner Res. 1991; 6: 495-500.
5. Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, van Hul W, Whyte MP, Nakatsuka K, Hovy L, Anderson DM., Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet. 2000; 24: 45-8.
6. Whyte MP., Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Ann NY Acad Sci. 2006; 1068: 143-64.
7. Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W., Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone. 2001; 28: 104-7.
8. Laurin N, Brown JP, Morissette J, Raymond V., Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002; 70: 1582-8.
9. Gennari L, Gianfrancesco F, Di Stefano M, Rendina D, Merlotti D, Esposito T, Gallone S, Fusco P, Rainero I, Fenoglio P, Mancini M, Martini G, Bergui S, De Filippo G, Isaia G, Strazzullo P, Nuti R, Mossetti G., SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res. 2010; 25: 1375-84.
10. Visconti MR, Langston AL, Alonso N, Goodman K, Selby PL, Fraser WD, Ralston SH., Mutations of SQSTM1 are associated with severity and clinical outcome in Paget disease of bone. J Bone Miner Res. 2010; 25: 2368-73.
11. Gennari L, Merlotti D, Martini G, Nuti R., Paget's disease of bone in Italy. J Bone Miner Res. 2006; 21 (Suppl 2): P14-21.
12. Rendina D, Gennari L, De Filippo G, Merlotti D, de Campora E, Fazioli F, Scarano G, Nuti R, Strazzullo P, Mossetti G., Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res. 2006; 21: 1828-35.
13. Jacobs TP, Michelsen J, Polay JS, D'Adamo AC, Canfield RE., Giant cell tumor in Paget's disease of bone: familial and geographic clustering. Cancer. 1979; 44: 742-7.
14. Magitsky S, Lipton JF, Reidy J, Vigorita VJ, Bryk E., Ultrastructural features of giant cell tumors in Paget's disease. Clin Orthop Relat Res. 2002; 402: 213-9.
15. Rendina D, Mossetti G, Soscia E, Sirignano C, Insabato L, Viceconti R, Ignarra R, Salvatore M, Nunziata V., Giant cell tumor and Paget's disease of bone in one family: geographic clustering. Clin Orthop Relat Res. 2004; 421: 218-24.
16. Singer FR, Mills BG., Giant cell tumor arising in Paget's disease of bone. Recurrences after 36 years. Clin Orthop Relat Res. 1993; 293: 293-301.
17. Gianfrancesco F, Rendina D, Di Stefano M, Mingione A, Esposito T, Merlotti D, Gallone S, Magliocca S, Goode A, Formicola D, Morello G, Layfield R, Frattini A, De Filippo G, Nuti R, Searle M, Strazzullo P, Isaia G, Mossetti G, Gennari L., A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease. J Bone Miner Res. 2012; 27: 443-52.
18. Metha PA, Dubrey SV., High output heart failure. Q J Med. 2009; 102: 235-41.
19. Lucas GJ, Riches PL, Hocking LJ, Cundy T, Nicholson GC, Walsh JP, Ralston SH., Identification of a major locus for Paget's disease on chromosome 10p13 in families of British descent. J Bone Miner Res. 2008; 23: 58-63.
20. Albagha OM, Visconti MR, Alonso N, Langston AL, Cundy T, Dargie R, Dunlop MG, Fraser WD, Hooper MJ, Isaia G, Nicholson GC, del Pino Montes J, Gonzalez-Sarmiento R, di Stefano M, Tenesa A, Walsh JP, Ralston SH., Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet. 2010; 42: 520-4.
21. Albagha OM, Wani SE, Visconti MR, Alonso N, Goodman K, Brandi ML, Cundy T, Chung PY, Dargie R, Devogelaer JP, Falchetti A, Fraser WD, Gennari L, Gianfrancesco F, Hooper MJ, Van Hul W, Isaia G, Nicholson GC, Nuti R, Papapoulos S, Montes Jdel P, Ratajczak T, Rea SL, Rendina D, Gonzalez-Sarmiento R, Di Stefano M, Ward LC, Walsh JP, Ralston SH., Genetic Determinants of Paget's Disease (GDPD) Consortium. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet. 2011; 43: 685-9.
22. Hansen MF, Seton M, Merchant A., Osteosarcoma in Paget's disease of bone. J Bone Miner Res. 2006; 21 (Suppl 2): P58-63.
23. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S., Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med. 2002; 347: 175-84.
24. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J., A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet. 2002; 11: 2119-27.
25. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE., Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin containing protein. Nat Genet. 2004; 36: 377-81.
26. Roodman GD., Studies in Paget's disease and their relevance to oncology. Semin Oncol. 2001; 28 (4 Suppl 11): 15-21.
27. Gebhart M, Vandeweyer E, Nemec E., Paget's disease of bone complicated by giant cell tumor. Clin Orthop Relat Res. 1998; 352: 187-93.
28. Dahlin DC., Caldwell Lecture. Giant cell tumor of bone: highlights of 407 cases. AJR Am J Roentgenol. 1985; 144: 955-60.
29. Potter HG, Schneider R, Ghelman B, Healey JH, Lane JM., Multiple giant cell tumors and Paget disease of bone: radiographic and clinical correlations. Radiology. 1991; 180: 261-4.
30. Pathak HJ, Nardi PM, Thornhill B., Multiple giant cell tumors complicating Paget's disease. AJR Am J Roentgenol. 1999; 172 (6): 1696-7.
31. Wu RK, Trumble TE, Ruwe PA., Familial incidence of Paget's disease and secondary osteogenic sarcoma: a report of three cases from a single family. Clin Orthop. 1991; 265: 306-9.
32. Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbertson HK., Evidence for secular change in Paget's disease. Bone. 1997; 20: 69-71.
33. Morales-Piga AA, Bachiller-Corral FJ, Abraira V, Beltran J, Rapado A., Is clinical expressiveness of Paget's disease of bone decreasing?. Bone. 2002; 30: 399-403.
34. Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T., Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int. 2004; 75: 358-64.
35. Michou L, Morissette J, Gagnon ER, Marquis A, Dellabadia M, Brown JP, Siris ES., Novel SQSTM1 mutations in patients with Paget's disease of bone in an unrelated multiethnic American population. Bone. 2011; 48: 456-60.